ArticlePloS one2024
How does company misconduct affect company survival risk?-evidence from China.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Based on the data of China's listed companies from 2000 to 2022, this study investigates how company misconduct affect company survival risk through survival analysis. The research results show that company misconduct significantly increases company survival risk. After considering endogeneity issues and conducting robustness tests, this conclusion still holds. Mechanism analysis reveals that company misconduct significantly increases enterprise survival risk by reducing investor confidence and increasing corporate financing constraints. Further analysis considering company and regional heterogeneity, which shows that non-state-owned, small-scale, low equity concentration, and eastern region company face more severe survival risk after misconduct. The findings extend the research on the influencing factor of company survival, and provide new empirical evidence for revealing how corporate misconduct affect company survival risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.